摘要
目的:探讨射频消融术对心动过速性心肌病的临床治疗效果。方法:对2012年1月-2013年12月在我院就诊的34例心动过速性心肌病患者采用射频消融术进行治疗,通过心电图、X线和超声心动图检测治疗前后患者的心率(HR)、心胸比率、左心室舒张末径(LVEDD)、左心室收缩末径(LVESD)和左室射血分数(LVEF),使用SF-36生活质量调查表对治疗前后患者的生活质量进行评分。结果:所有患者经射频消融术治疗后恢复窦性心律,1例复发,复发率为3.03%,患者的呼吸困难、心悸等临床症状明显缓解。治疗后6个月,患者的HR、心胸比率、LVEDD、LVESD和LVEF均较治疗前显著改善,差异均具有统计学意义(均P<0.05);治疗后1周,患者的生理机能(PF)、生理职能(RP)、躯体疼痛(BP)、一般健康(GH)、精力(VT)、社会功能(SF)、情感职能(RE)和精神健康(MH)评分均较治疗前显著升高,差异均具有统计学意义(均P<0.05)。结论:采用射频消融术治疗心动过速性心肌病的临床效果好,能显著提高患者的生活质量,并改善患者的心功能。
Objective： To explore the clinical effect of radiofrequency catheter ablation on tachycardiomyopathy. Methods： 34 cases of patients with tachycardiomyopathy who were treated by radiofrequency catheter ablation in our hospital from January 2012to December 2013 were selected. The ECG, X-ray and echocardiography were used to detect the heart rate （HR）, cardiothoracic ratio, left ventricular end-diastolic diameter （LVEDD）, left ventricular end-systolic diameter （LVESD） and left ventricular ejection fraction （LVEF） before and after treatment. The patients＇ quality of life were evaluated and compared by the SF-36 questionnaire before and after treatment. Results： All the patients treated by radiofrequency catheter ablation therapy restored sinus rhythm, recurrence was observed in only one case, the recurrent rate was 3.03%, the clinical symptoms of dyspnea, palpitations were all apparently eased. At 6 months after treatment, the HR, cardiothoracic ratio, LVEDD, LVESD, and LVEF of patients were all significantly improved compared with those before treatment （P〈0.05）. At 1 week after treatment, the scores of PF, RP, BP, GH, VT, SF, RE and MH were all obviously increased compared with those before treatment （P〈0.05）. Conclusion： Radiofrequency catheter ablation was effective in the treatment of tachycardiomyopathy, which could significantly improve the patients＇ quality of life, and improve the heart function.
出处
《现代生物医学进展》
CAS
2015年第9期1671-1673,1684,共4页
Progress in Modern Biomedicine
基金
湖北省教委基金课题(99A081)
关键词
心动过速性心肌病
射频消融术
临床疗效
Tachycardiomyopathy
Radiofrequency catheter ablation
Clinical efficacy
